Company Quick10K Filing
Arch Therapeutics
10-Q 2021-03-31 Filed 2021-05-06
S-1 2021-02-26 Public Filing
10-Q 2020-12-31 Filed 2021-02-12
10-K 2020-09-30 Filed 2020-12-11
10-Q 2020-06-30 Filed 2020-07-23
10-Q 2020-03-31 Filed 2020-05-05
10-Q 2019-12-31 Filed 2020-01-30
S-1 2019-11-21 Public Filing
10-K 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-14
10-Q 2018-12-31 Filed 2019-02-01
10-K 2018-09-30 Filed 2018-12-18
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-04-26
10-Q 2017-12-31 Filed 2018-02-01
10-K 2017-09-30 Filed 2017-11-15
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-05-02
10-Q 2016-12-31 Filed 2017-02-01
10-K 2016-09-30 Filed 2016-12-05
10-Q 2016-06-30 Filed 2016-07-28
10-Q 2016-03-31 Filed 2016-04-28
10-Q 2015-12-31 Filed 2016-02-12
10-K 2015-09-30 Filed 2015-12-11
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-07
10-Q 2014-12-31 Filed 2015-02-09
10-K 2014-09-30 Filed 2014-12-12
10-Q 2014-06-30 Filed 2014-08-06
10-Q 2014-03-31 Filed 2014-05-15
10-Q 2013-12-31 Filed 2014-02-14
10-K 2013-09-30 Filed 2013-12-27
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-20
10-Q 2012-12-31 Filed 2013-02-14
10-K 2012-09-30 Filed 2012-12-31
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-03
8-K 2021-02-11 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2021-01-04 Regulation FD, Other Events, Exhibits
8-K 2020-12-31 Officers
8-K 2020-11-06
8-K 2020-08-11
8-K 2020-07-01
8-K 2020-06-03
8-K 2020-05-20
8-K 2020-04-25
8-K 2020-04-13
8-K 2020-03-23
8-K 2019-10-16
8-K 2019-10-07
8-K 2019-08-05
8-K 2019-05-12
8-K 2019-04-24
8-K 2018-12-17
8-K 2018-12-06
8-K 2018-12-04
8-K 2018-11-28
8-K 2018-11-26
8-K 2018-10-01
8-K 2018-09-05
8-K 2018-07-17
8-K 2018-06-28
8-K 2018-06-26
8-K 2018-06-15
8-K 2018-05-08
8-K 2018-03-12
8-K 2018-02-05

Arch Therapeutics Financials

ARTH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
ENETI INC. (NETI)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
Exantas Capital (XAN)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
Blue Star Foods Corp. (BSFC)
1st Financial Services Corp (FFIS)
Oak Valley Bancorp (OVLY) 138,267 1.6 1% 1,101,132 991,812 0 0 9,298 13,630 21,873
Oaktree Acquisition (OAC) -4.3 0% 204,095 8,231 0 0 419 419 -1,800
Verus International (VRUS)
Kohl's (KSS) 7,892,760 39% 6.2 4% 15,739,000 10,384,000 19,965,000 7,880,000 698,000 1,510,000 9,402,760
JM Smucker (SJM) 12,454,015 38% 13.9 3% 16,791,000 8,695,700 7,650,700 2,919,800 558,700 1,284,100 17,789,215
1st United Bancorp (FUBC)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5204304765579452,6311,8038347835743,2743,9602,8151,6695,7455,0363,7887,2306,1695,9944,9583,3786,4894,6673,3781,9563,1822,180
Accounts Receivable
Inventory347
PP&E06000444888131623282828282828
Assets4781,5879952,6731,8358778246063,3184,0032,8681,7595,9035,1443,9027,5796,3236,0905,0433,4676,5994,8403,6372,4273,7912,902
Accounts Payable1002308315310104166176294204500232268136493375272209206265289317183161131176129534
Long-Term Debt1,880945947950953956959961964967970972975780000
Liabilities4191,4001,48511,1619,7327,7696,2516,5359,3832,4631,9591,6421,9581,9831,4102,9972,9403,8641,9291,3924,3493,4804,3012,6273,9623,710
Stockholders' Equity519-1-3-758187-490-8,489-7,897-6,892-5,426-5,929-6,0651,5409101183,9453,1612,4924,5823,3842,2273,1142,0752,2511,360-664-201-172-807
Income Statement ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000000000000000000000000000
Cost of Revenue00
Gross Profit00
R&D441572574873205264004025254334143864394443497105355015811,014634655589629639540
SG&A9621154518055238088268638708538131,1648668681,2941,3391,0271,4941,3061,3801,0029999861,5791,179879934984
Tax0000000000
Net Income-9-6-21-1-5-514-962-808-8,380411635379-834-1,395-1,097-1,157-1,253-1,766-1,817-1,402-1,869-1,776-2,742389-1,555-2,213-1,435-2,600170-1,289-828
Cash Flow ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-9-5-15-1-9-657-669-612-1,128-738-969-851-817-1,613-1,145-1,186-1,331-1,085-1,375-2,033-980-1,096-1,574-1,418-1,826-1,322-1,421-1,544-980
Cash Investing0000-400-3-6-600000
Cash Financing0200061,1217501,0002,814-9108003,5172,2990405,4073771315,476-826304,53543202,770-21